| Market revenue in 2025 | USD 3.6 million |
| Market revenue in 2033 | USD 7.4 million |
| Growth rate | 9.1% (CAGR from 2026 to 2033) |
| Largest segment | Implanted heart pump devices |
| Fastest growing segment | Implanted Heart Pump Devices |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Extracorporeal Heart Pump Devices, Implanted Heart Pump Devices |
| Key market players worldwide | Abbott Laboratories, Johnson & Johnson, Getinge AB ADR, LivaNova PLC, Teleflex Inc, Berlin Heart GmbH, SynCardia Systems, Jarvik Heart, BiVACOR, Leviticus Cardio |
Publish Date: Jun 24, 2026
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Johnson & Johnson | View profile | 134,400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | www.jnj.com |
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Getinge AB ADR | View profile | 11,862 | Lindholmspiren 7A, P.O. Box 8861, Gothenburg, Sweden, SE-417 56 | www.getinge.com |
| Teleflex Inc | View profile | 14,500 | 550 East Swedesford Road, Suite 400, Wayne, PA, United States, 19087 | www.teleflex.com |
| LivaNova PLC | View profile | 2,900 | 20 Eastbourne Terrace, London, United Kingdom, W2 6LG | www.livanova.com |
| BiVACOR | View profile | 11-50 | Houston, Texas, United States, North America | bivacor.com |
| Berlin Heart GmbH | View profile | 501-1000 | Berlin, Berlin, Germany, Europe | www.berlinheart.de/ |
| SynCardia Systems | View profile | 101-250 | Tucson, Arizona, United States, North America | www.syncardia.com/ |
| Jarvik Heart | View profile | 51-100 | New York, New York, United States, North America | www.jarvikheart.com/ |
| Leviticus Cardio | View profile | 1-10 | Petah Tikwah, HaMerkaz, Israel, Asia | www.leviticus-cardio.com/ |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Heart Pump Device Market Outlook will help companies and investors design strategic landscapes.
Implanted Heart Pump Devices was the largest segment with a revenue share of 80.56% in 2025.
Horizon Databook has segmented the Kuwait heart pump device market based on extracorporeal heart pump devices, implanted heart pump devices covering the revenue growth of each sub-segment from 2021 to 2033.
Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait Heart Pump Device Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Kuwait Heart Pump Device Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
